GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Purchased by TIAA Trust National Association

TIAA Trust National Association raised its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 1.3% during the first quarter, Holdings Channel.com reports. The institutional investor owned 11,276 shares of the company’s stock after buying an additional 149 shares during the period. TIAA Trust National Association’s holdings in GE HealthCare Technologies were worth $1,025,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the stock. Wynn Capital LLC boosted its holdings in shares of GE HealthCare Technologies by 4.1% during the first quarter. Wynn Capital LLC now owns 3,125 shares of the company’s stock worth $284,000 after purchasing an additional 122 shares during the last quarter. Byrne Asset Management LLC boosted its holdings in shares of GE HealthCare Technologies by 0.8% during the first quarter. Byrne Asset Management LLC now owns 16,424 shares of the company’s stock worth $1,493,000 after purchasing an additional 126 shares during the last quarter. WASHINGTON TRUST Co boosted its holdings in shares of GE HealthCare Technologies by 7.7% during the first quarter. WASHINGTON TRUST Co now owns 1,853 shares of the company’s stock worth $168,000 after purchasing an additional 133 shares during the last quarter. Fiduciary Trust Co boosted its holdings in shares of GE HealthCare Technologies by 1.8% during the fourth quarter. Fiduciary Trust Co now owns 7,696 shares of the company’s stock worth $595,000 after purchasing an additional 133 shares during the last quarter. Finally, Quent Capital LLC boosted its holdings in shares of GE HealthCare Technologies by 21.3% during the first quarter. Quent Capital LLC now owns 780 shares of the company’s stock worth $71,000 after purchasing an additional 137 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Insider Transactions at GE HealthCare Technologies

In other GE HealthCare Technologies news, insider Frank R. Jimenez bought 1,315 shares of the company’s stock in a transaction dated Wednesday, May 1st. The shares were acquired at an average cost of $76.52 per share, with a total value of $100,623.80. Following the completion of the transaction, the insider now owns 75,796 shares in the company, valued at $5,799,909.92. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In related news, CTO Taha Kass-Hout sold 3,300 shares of the business’s stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $78.70, for a total transaction of $259,710.00. Following the sale, the chief technology officer now owns 67,300 shares of the company’s stock, valued at $5,296,510. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Frank R. Jimenez bought 1,315 shares of the company’s stock in a transaction that occurred on Wednesday, May 1st. The shares were purchased at an average cost of $76.52 per share, for a total transaction of $100,623.80. Following the acquisition, the insider now owns 75,796 shares of the company’s stock, valued at $5,799,909.92. The disclosure for this purchase can be found here. Over the last ninety days, insiders have sold 90,482 shares of company stock valued at $7,369,137. 0.27% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several brokerages recently weighed in on GEHC. The Goldman Sachs Group began coverage on GE HealthCare Technologies in a research report on Thursday, May 30th. They issued a “neutral” rating and a $87.00 target price on the stock. Bank of America cut their target price on GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 1st. Citigroup increased their target price on GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. Evercore ISI increased their target price on GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a research report on Thursday, April 4th. Finally, Mizuho cut their target price on GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating on the stock in a research report on Wednesday, May 1st. Five research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $94.09.

GE HealthCare Technologies Stock Down 0.6 %

NASDAQ:GEHC traded down $0.51 during mid-day trading on Friday, hitting $80.44. The company had a trading volume of 2,428,375 shares, compared to its average volume of 2,743,324. The business has a fifty day simple moving average of $78.74 and a 200-day simple moving average of $82.05. The company has a current ratio of 1.06, a quick ratio of 0.83 and a debt-to-equity ratio of 1.11. GE HealthCare Technologies Inc. has a 1 year low of $62.35 and a 1 year high of $94.50. The firm has a market capitalization of $36.72 billion, a price-to-earnings ratio of 23.52, a PEG ratio of 2.89 and a beta of 1.20.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings data on Tuesday, April 30th. The company reported $0.90 EPS for the quarter, meeting the consensus estimate of $0.90. GE HealthCare Technologies had a return on equity of 25.32% and a net margin of 8.05%. The company had revenue of $4.65 billion for the quarter, compared to analyst estimates of $4.80 billion. During the same period last year, the company posted $0.85 earnings per share. The firm’s revenue was down 1.2% compared to the same quarter last year. Equities analysts forecast that GE HealthCare Technologies Inc. will post 4.27 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, August 15th. Stockholders of record on Friday, July 19th will be given a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.15%. The ex-dividend date is Friday, July 19th. GE HealthCare Technologies’s payout ratio is 3.51%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.